Particle.news

FDA Lists Nine Eye-Care Products in Recall Over Sterility Concerns

The manufacturer initiated the action that the FDA classified as Class II, prompting consumers to check lot numbers and stop using matched products.

Overview

  • Sterling Pharmaceutical Services LLC began the recall on August 20, 2026 and the FDA designated it Class II on September 21, 2026, a classification that signals possible temporary or reversible health effects.
  • The FDA’s enforcement notice covers nine products totaling 747,844 units, including lubricant drops, a hypertonicity solution and a nighttime ointment.
  • Walgreens-branded lubricant eye drops make up the largest single share of the recalled units with about 301,114 individual bottles and 199,600 two-count packs.
  • The recall stems from a lack of assurance that the products are sterile, and the FDA warns that nonsterile eye products can cause eye infections or irritation because the eye is vulnerable to contamination.
  • Consumers should compare product name, lot number and expiration date with the FDA listing, stop using any matched items, consult a health care provider for symptoms, and follow retailer or manufacturer guidance for returns or refunds where provided.